JP2016502980A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502980A5
JP2016502980A5 JP2015546771A JP2015546771A JP2016502980A5 JP 2016502980 A5 JP2016502980 A5 JP 2016502980A5 JP 2015546771 A JP2015546771 A JP 2015546771A JP 2015546771 A JP2015546771 A JP 2015546771A JP 2016502980 A5 JP2016502980 A5 JP 2016502980A5
Authority
JP
Japan
Prior art keywords
agent according
respiratory disease
cells
stro
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015546771A
Other languages
English (en)
Japanese (ja)
Other versions
JP6313327B2 (ja
JP2016502980A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/001454 external-priority patent/WO2014089625A1/en
Publication of JP2016502980A publication Critical patent/JP2016502980A/ja
Publication of JP2016502980A5 publication Critical patent/JP2016502980A5/ja
Application granted granted Critical
Publication of JP6313327B2 publication Critical patent/JP6313327B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015546771A 2012-12-12 2013-12-12 呼吸器系疾患を治療又は予防する方法 Active JP6313327B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018055386A Division JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法

Publications (3)

Publication Number Publication Date
JP2016502980A JP2016502980A (ja) 2016-02-01
JP2016502980A5 true JP2016502980A5 (enExample) 2017-02-02
JP6313327B2 JP6313327B2 (ja) 2018-04-18

Family

ID=50933587

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015546771A Active JP6313327B2 (ja) 2012-12-12 2013-12-12 呼吸器系疾患を治療又は予防する方法
JP2018055386A Active JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法
JP2020026138A Pending JP2020097618A (ja) 2012-12-12 2020-02-19 呼吸器系疾患を治療又は予防する方法
JP2022024306A Active JP7420844B2 (ja) 2012-12-12 2022-02-18 呼吸器系疾患を治療又は予防する方法
JP2024002878A Pending JP2024041904A (ja) 2012-12-12 2024-01-11 呼吸器系疾患を治療又は予防する方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018055386A Active JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法
JP2020026138A Pending JP2020097618A (ja) 2012-12-12 2020-02-19 呼吸器系疾患を治療又は予防する方法
JP2022024306A Active JP7420844B2 (ja) 2012-12-12 2022-02-18 呼吸器系疾患を治療又は予防する方法
JP2024002878A Pending JP2024041904A (ja) 2012-12-12 2024-01-11 呼吸器系疾患を治療又は予防する方法

Country Status (11)

Country Link
US (3) US10028979B2 (enExample)
EP (1) EP2931373B1 (enExample)
JP (5) JP6313327B2 (enExample)
KR (1) KR101748712B1 (enExample)
CN (2) CN115919901A (enExample)
AU (4) AU2013360026B2 (enExample)
CA (1) CA2893951C (enExample)
ES (1) ES2759281T3 (enExample)
IL (1) IL239309A0 (enExample)
SG (2) SG10201807682PA (enExample)
WO (1) WO2014089625A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101748712B1 (ko) 2012-12-12 2017-06-19 메소블라스트, 아이엔씨. 호흡기 질환의 치료 또는 예방 방법
WO2016049156A1 (en) * 2014-09-23 2016-03-31 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
AU2018333272B2 (en) * 2017-09-15 2022-12-08 Cynata Therapeutics Limited Method for treating allergic airways disease (AAD)/ asthma
EP4098267A4 (en) * 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
WO2003070922A1 (en) * 2002-02-19 2003-08-28 Medipost Co., Ltd. Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CN101506355B (zh) * 2004-09-24 2012-06-27 成血管细胞系统公司 多能扩增间充质前体细胞子代(memp)及其应用
ES2654428T3 (es) * 2005-04-12 2018-02-13 Mesoblast, Inc. Aislamiento de células multipotenciales adultas por fosfatasa alcalina no específica de tejido
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
TWI603736B (zh) * 2007-08-06 2017-11-01 安吉歐公司 活體內產生、修補及/或維持結締組織的方法
KR20100076031A (ko) * 2007-10-17 2010-07-05 티엑셀 Tr1 세포, 중간엽 줄기 세포 및 이들의 용도
KR101708067B1 (ko) * 2008-09-03 2017-02-17 메소블라스트, 아이엔씨. 혈액 형성 전구 세포의 증식
CN106727703B (zh) * 2010-07-02 2021-04-13 迈索布拉斯特股份有限公司 治疗移植物抗宿主疾病的方法
CA2829586C (en) * 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
CN103841983B (zh) * 2011-06-03 2018-11-02 麦瑟布莱斯特公司 治疗或预防神经性疾病的方法
KR101748712B1 (ko) 2012-12-12 2017-06-19 메소블라스트, 아이엔씨. 호흡기 질환의 치료 또는 예방 방법

Similar Documents

Publication Publication Date Title
JP2016502980A5 (enExample)
Pappas et al. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma
Lan et al. Role of protease-activated receptors in airway function: a target for therapeutic intervention?
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
RU2015143254A (ru) Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток
EA201190108A1 (ru) Фармацевтическая композиция для ингаляции
EA201000785A1 (ru) Композиции для доставки в легкие
Holland et al. Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury
PE20141012A1 (es) Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparacion
EA201590019A1 (ru) Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
CY1116824T1 (el) Ενωσεις πυρουβαμιδιου ως αναστολεις της αλλεργιογονου πεπτιδασης ομαδας 1 των ακαρεων σκονης
SG10201807682PA (en) Methods of Treating or Preventing Respiratory Conditions
JP2013507945A5 (enExample)
EP2120935A4 (en) NOVEL COMBINATION OF COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES, IN PARTICULAR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY (COPD) AND ASTHMA
WO2015049519A3 (en) Method and apparatus for making compositions for pulmonary administration
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
JP2013194009A5 (enExample)
Gazzola Allergy immunotherapy tablets prove successful for both grass pollen and dust mites
CN201879100U (zh) 一种桌子
Hernandez-Vasquez Burden of smoking-related disease and potential impact of cigarette price increase in Peru
伍福生 et al. Indoor allergens and microbial bio-contaminants in homes of asthmatic children in central Taiwan
Xiong et al. Lung Mononuclear Phagocytes Require Functional CX3CR1 To Express Inflammatory Cytokines During Cigarette Smoke Exposure
JP2018510153A5 (enExample)
Singhera et al. Corticosteroid Exposure Alters The Airway Epithelial Response To Injury